Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT04843072
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 600 participants
- Registry
-
NCT04843072
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Austria, Canada, Denmark, France, Germany, Greece, Italy, Netherlands, Portugal, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT04843072. Randomized; no masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2028-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
- Acronym
- BASELINE
- Condition
- Valve Heart Disease
- Intervention (Device)
- EVOLUT R/PRO/PRO+/FX bioprosthesis
- Intervention (Device)
- Edwards Sapien S3/Ultra bioprosthesis
- Intervention (Device)
- MYVAL/Octacor/Octapro bioprosthesis
- Lead sponsor
- Erasmus Medical Center
- Collaborator
- Cedars-Sinai Medical Center
Record details
- Record id
cardio:ct-nct04843072- Content hash
9eaa2a18972c675400005ef77ab07194dbd9b9308bb0ac31b5618903c3cae88a